InMed Pharmaceuticals Inc. - Common Shares, no par value (INM)
CUSIP: 457637601
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 804,525
- Total 13F shares
- 1,141,865
- Share change
- +701,594
- Total reported value
- $265,983
- Price per share
- $0.24
- Number of holders
- 12
- Value change
- +$152,049
- Number of buys
- 7
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 457637601?
CUSIP 457637601 identifies INM - InMed Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 457637601:
Top shareholders of INM - InMed Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13F
|
Company |
38%
|
307,236
|
$81,571 | — | 30 Jun 2024 | |
| Virtu Financial LLC |
13F
|
Company |
11%
|
86,684
|
$23,000 | — | 30 Jun 2024 | |
| Bruce Colwill |
3/4/5
|
CFO |
—
class O/S missing
|
11,515
|
$10,294 | — | 24 Jan 2022 | |
| XTX Topco Ltd |
13F
|
Company |
2.2%
|
17,819
|
$4,731 | — | 30 Jun 2024 | |
| HRT FINANCIAL LP |
13F
|
Company |
2%
|
15,996
|
$4,000 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.5%
|
12,097
|
$3,212 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.02%
|
200
|
$54 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
100
|
$26 | — | 30 Jun 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0.01%
|
85
|
$21 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
32
|
$7 | — | 30 Jun 2024 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
21
|
$6 | — | 30 Jun 2024 | |
| Global Retirement Partners, LLC |
13F
|
Company |
0%
|
6
|
$2 | — | 30 Jun 2024 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
2
|
$1 | — | 30 Jun 2024 | |
| Mrs. Alexandra Diane Janet Mancini |
3/4/5
|
Consultant |
—
mixed-class rows
|
104,606
mixed-class rows
|
— | — | 31 Jul 2024 | |
| Mr. Jonathan Tegge |
3/4/5
|
Interim CFO |
—
class O/S missing
|
31,400
|
— | — | 23 Dec 2023 | |
| Catherine Sazdanoff |
3/4/5
|
Director |
—
class O/S missing
|
29,091
|
— | — | 29 Dec 2021 | |
| Adam D. Cutler |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Mr. William J. Garner |
3/4/5
|
Director |
—
class O/S missing
|
16,122
|
— | — | 24 Jan 2022 | |
| Ms. Sarah Li |
3/4/5
|
VP Accounting & Controller |
—
class O/S missing
|
4,002
|
— | — | 16 Dec 2022 |
Institutional Holders of InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) as of Q3 2024
As of 30 Sep 2024,
InMed Pharmaceuticals Inc. - Common Shares, no par value (INM) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,141,865 shares.
The largest 10 holders included
AdvisorShares Investments LLC, UBS Group AG, CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, HRT FINANCIAL LP, Virtu Financial LLC, Baader Bank Aktiengesellschaft, BANK OF AMERICA CORP /DE/, OSAIC HOLDINGS, INC., and AllSquare Wealth Management LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
10
Q3 2024 holders
12
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.